Abstract
Neurodegenerative diseases account for a significant portion of public health concerns particularly in the aging population. The dysfunction of interfilament proteins has been identified as a key event in the initiation of neurodegeneration and subsequent progression to neurodegenerative diseases. In addition, several studies have found associations between the dysfunction of interfilament proteins and exposure to environmental contaminants. Therefore, in this review, the role of interfilament proteins in neuronal cells, their connection to neurotoxicity from environmental contaminants, and finally the resulting neurodegeneration are discussed.
Similar content being viewed by others
References
Adya KA, Inamadar AC, Janagond AB, Palit A (2020) Epidermolytic nevus: an instance of mosaic epidermolytic ichthyosis. Indian Dermatology Online Journal 11(2):272
Agam G, Damri O, Bar-Yosef T (2019) Dual role of autophagy in diseases of the central nervous system. Frontiers in cellular neuroscience 13:196
Al Mamun, A., M. S. Uddin, M. T. Kabir, S. Khanum, M. S. Sarwar, B. Mathew, A. Rauf, M. Ahmed and G. M. Ashraf (2020). "Exploring the promise of targeting ubiquitin-proteasome system to combat Alzheimer’s disease." Neurotoxicity Research: 1–10.
Andersen PM, Al-Chalabi A (2011) Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 7(11):603–615
Attoff K, Kertika D, Lundqvist J, Oredsson S, Forsby A (2016) Acrylamide affects proliferation and differentiation of the neural progenitor cell line C17. 2 and the neuroblastoma cell line SH-SY5Y. Toxicol In Vitro 35:100–111
Bal-Price A, Crofton KM, Sachana M, Shafer TJ, Behl M, Forsby A, Hargreaves A, Landesmann B, Lein PJ, Louisse J, Monnet-Tschudi F, Paini A, Rolaki A, Schrattenholz A, Suñol C, van Thriel C, Whelan M, Fritsche E (2015) Putative adverse outcome pathways relevant to neurotoxicity. Crit Rev Toxicol 45(1):83–91
Bär H, Strelkov SV, Sjöberg G, Aebi U, Herrmann H (2004) The biology of desmin filaments: how do mutations affect their structure, assembly, and organisation? J Struct Biol 148(2):137–152
Barnes JR, Mukherjee B, Rogers BC, Nafar F, Gosse M, Parsons MP (2020) The relationship between glutamate dynamics and activity-dependent synaptic plasticity. J Neurosci 40(14):2793–2807
Bott CJ, Winckler B (2020) Intermediate filaments in developing neurons: beyond structure. Cytoskeleton 77(3–4):110–128
Brady, S. (2005). Basic neurochemistry: molecular, cellular and medical aspects, Elsevier.
Bragina L, Conti F (2018) Expression of neurofilament subunits at neocortical glutamatergic and GABAergic synapses. Front Neuroanat 12:74
Brandt N, Vierk R, Fester L, Anstötz M, Zhou L, Heilmann LF, Kind S, Steffen P, Rune GM (2020) Sex-specific difference of hippocampal synaptic plasticity in response to sex neurosteroids. Cereb Cortex 30(4):2627–2641
Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A (2001) Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 27(1):117–120
Brown SC, Torelli S, Ugo I, De Biasia F, Howman EV, Poon E, Britton J, Davies KE, Muntoni F (2005) Syncoilin upregulation in muscle of patients with neuromuscular disease. Muscle Nerve 32(6):715–725
Cai Q, Jeong YY (2020) Mitophagy in Alzheimer’s disease and other age-related neurodegenerative diseases. Cells 9(1):150
Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IRA, Gearing M, Juncos JL, Glass JD, Yokoo H, Nakazato Y, Mosaheb S, Thorpe JR, Uryu K, Lee VMY, Trojanowski JQ (2004) Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 63(8):1376–1384
Calderone A, Formenti M, Aprea F, Papa M, Alberghina L, Colangelo AM, Bertolazzi P (2016) Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure. BMC Syst Biol 10(1):25
Chen QS, Kagan BL, Hirakura Y, Xie CW (2000) Impairment of hippocampal long-term potentiation by Alzheimer amyloid β-peptides. J Neurosci Res 60(1):65–72
Chen Y, Xie HQ, Sha R, Xu T, Zhang S, Fu H, Xia Y, Liu Y, Xu L, Zhao B (2020) 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin and up-regulation of neurofilament expression in neuronal cells: evaluation of AhR and MAPK pathways. Environ Int 134:105193
Cho TM, Tiffany-Castiglioni E (2004) Neurofilament 200 as an indicator of differences between mipafox and paraoxon sensitivity in Sy5Y neuroblastoma cells. Journal of Toxicology and Environmental Health, Part A 67(13):987–1000
Coulombe PA, Kerns ML, Fuchs E (2009) Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility. J Clin Investig 119(7):1784–1793
Dawson G, Seabrook G, Zheng H, Smith D, Graham S, G. O’dowd, B. Bowery, S. Boyce, M. Trumbauer and H. Chen, (1999) Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the β-amyloid precursor protein. Neuroscience 90(1):1–13
De Luca C, Colangelo AM, Virtuoso A, Alberghina L, Papa M (2020) Neurons, glia, extracellular matrix and neurovascular unit: a systems biology approach to the complexity of synaptic plasticity in health and disease. Int J Mol Sci 21(4):1539
Dewachter I, Reversé D, Caluwaerts N, Ris L, Kuipéri C, Van den Haute C, Spittaels K, Umans L, Serneels L, Thiry E (2002) Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J Neurosci 22(9):3445–3453
Fasolo, A. (2011). The theory of evolution and its impact, Springer Milan.
Ferrer, I., P. Andrés-Benito, M. V. Zelaya, M. E. E. Aguirre, M. Carmona, K. Ausín, M. Lachén-Montes, J. Fernández-Irigoyen, E. Santamaría and J. A. del Rio (2020). "Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy." Acta Neuropathologica: 1–37.
Gao J, Naughton SX, Beck WD, Hernandez CM, Wu G, Wei Z, Yang X, Bartlett MG, Terry AV Jr (2017) Chlorpyrifos and chlorpyrifos oxon impair the transport of membrane bound organelles in rat cortical axons. Neurotoxicology 62:111–123
Gao J, Naughton SX, Wulff H, Singh V, Beck WD, Magrane J, Thomas B, Kaidery NA, Hernandez CM, Terry AV (2016) Diisopropylfluorophosphate impairs the transport of membrane-bound organelles in rat cortical axons. J Pharmacol Exp Ther 356(3):645–655
Grad LI, Rouleau GA, Ravits J, Cashman NR (2017) Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harbor perspectives in medicine 7(8):a024117
Guo, W., K. S. Dittlau and L. Van Den Bosch (2020). Axonal transport defects and neurodegeneration: molecular mechanisms and therapeutic implications. Seminars in cell & developmental biology, Elsevier.
Hargreaves, A. J., M. Sachana and J. Flaskos (2019). Cytoskeletal disruption as a biomarker of developmental neurotoxicity. Biomarkers in Toxicology, Elsevier: 1033–1046.
Hashimoto R, Nakamura Y, Komai S, Kashiwagi Y, Tamura K, Goto T, Aimoto S, Kaibuchi K, Shiosaka S, Takeda M (2000) Site-specific phosphorylation of neurofilament-L is mediated by calcium/calmodulin-dependent protein kinase II in the apical dendrites during long-term potentiation. J Neurochem 75(1):373–382
Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J (2014) Clinical development success rates for investigational drugs. Nat Biotechnol 32(1):40–51
Homma, T. and J. Fujii (2020). "Emerging connections between oxidative stress, defective proteolysis, and metabolic diseases." Free Radical Research: 1–16.
Kedia N, Arhzaouy K, Pittman SK, Sun Y, Batchelor M, Weihl CC, Bieschke J (2019) Desmin forms toxic, seeding-competent amyloid aggregates that persist in muscle fibers. Proc Natl Acad Sci 116(34):16835–16840
Kimmelman J (2018) Better to be in the placebo arm for trials of neurological therapies? Cell Transplant 27(4):677–681
Klement, W., F. Oliviero, G. Gangarossa, E. Zub, F. De Bock, I. Forner, M. Blaquiere, F. Lasserre, J.-M. Pascussi and T. Maurice (2020). "Life-long dietary pesticides cocktail induces astrogliosis along with behavioral adaptations and activates p450 metabolic pathways." Neuroscience.
Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, Kösel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) AlaSOPro mutation in the gene encoding α-synuclein in Parkinson’s disease. Nat Genet 18(2):106–108
Kurup N, Li Y, Goncharov A, Jin Y (2018) Intermediate filament accumulation can stabilize microtubules in Caenorhabditis elegans motor neurons. Proc Natl Acad Sci 115(12):3114–3119
Laplante M, Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci 122(20):3589–3594
Larsen KE, Schmitz Y, Troyer MD, Mosharov E, Dietrich P, Quazi AZ, Savalle M, Nemani V, Chaudhry FA, Edwards RH (2006) α-Synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci 26(46):11915–11922
Lau A, Tymianski M (2010) Glutamate receptors, neurotoxicity and neurodegeneration. Pflügers Archiv-European Journal of Physiology 460(2):525–542
Lee H-G, Perry G, Moreira PI, Garrett MR, Liu Q, Zhu X, Takeda A, Nunomura A, Smith MA (2005) Tau phosphorylation in Alzheimer’s disease: pathogen or protector? Trends in molecular medicine 11(4):164–169
Liu Q, Xie F, Siedlak S, Nunomura A, Honda K, Moreira P, Zhua X, Smith M, Perry G (2004) Neurofilament proteins in neurodegenerative diseases. Cellular and Molecular Life Sciences CMLS 61(24):3057–3075
Magalingam KB, Radhakrishnan A, Ping NS, Haleagrahara N (2018) Current concepts of neurodegenerative mechanisms in Alzheimer’s disease. Biomed Res Int 2018:3740461
Maiuri T, Mocle AJ, Hung CL, Xia J, van Roon-Mom WM, Truant R (2017) Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex. Hum Mol Genet 26(2):395–406
Mateos-Aparicio P, Rodríguez-Moreno A (2020) Calcium dynamics and synaptic plasticity. Springer, Calcium Signaling, pp 965–984
Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K (2019) Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA neurology 76(7):791–799
Mertens J, Stüber K, Poppe D, Doerr J, Ladewig J, Brüstle O, Koch P (2013a) Embryonic stem cell-based modeling of tau pathology in human neurons. Am J Pathol 182(5):1769–1779
Mertens J, Stüber K, Poppe D, Doerr J, Ladewig J, Brüstle O, Koch P (2013b) Embryonic stem cell-based modeling of tau pathology in human neurons. The American journal of pathology 182(5):1769–1779
Montagna E, Dorostkar MM, Herms J (2017) The role of APP in structural spine plasticity. Frontiers in molecular neuroscience 10:136
Müller M, Bhattacharya SS, Moore T, Prescott Q, Wedig T, Herrmann H, Magin TM (2009) Dominant cataract formation in association with a vimentin assembly disrupting mutation. Hum Mol Genet 18(6):1052–1057
Murphy-Royal C, Johnston AD, Boyce AK, Diaz-Castro B, Institoris A, Peringod G, Zhang O, Stout RF, Spray DC, Thompson RJ (2020) Stress gates an astrocytic energy reservoir to impair synaptic plasticity. Nature communications 11(1):1–18
O’Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci 34:185–204
Oka M, Kudo H, Sugama N, Asami Y, Takehana M (2008) The function of filensin and phakinin in lens transparency. Molecular vision 14:815–822
Olanow CW, McNaught KSP (2006) Ubiquitin–proteasome system and Parkinson’s disease. Movement disorders: official journal of the Movement Disorder Society 21(11):1806–1823
Patil V, Patil AA, Patil S, Khairnar N, Tarwal N, Vanalakar S, Bulakhe R, In I, Patil P, Dongale T (2020) Bipolar resistive switching, synaptic plasticity and non-volatile memory effects in the solution-processed zinc oxide thin film. Mater Sci Semicond Process 106:104769
Peng, C., J. Q. Trojanowski and V. M.-Y. Lee (2020). "Protein transmission in neurodegenerative disease." Nature Reviews Neurology: 1–14.
Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10(7):S10–S17
Roth RH, Cudmore RH, Tan HL, Hong I, Zhang Y, Huganir RL (2020) “Cortical synaptic AMPA receptor plasticity during motor learning.” Neuron 105(5):895–908
Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344(22):1688–1700
Roy S (2020) Finding order in slow axonal transport. Curr Opin Neurobiol 63:87–94
Seki T, Kanagawa M, Kobayashi K, Kowa H, Yahata N, Maruyama K, Iwata N, Inoue H, Toda T (2020) Galectin 3–binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein. J Biol Chem 295(11):3678–3691
Shah, A., J. Morris and M. Wray (2020). "Pathogenesis of Alzheimer’s disease: multiple interacting causes against which amyloid precursor protein protects." Medical Hypotheses: 110035.
Sindi RA, Harris W, Arnott G, Flaskos J, Mills CL, Hargreaves AJ (2016) Chlorpyrifos-and chlorpyrifos oxon-induced neurite retraction in pre-differentiated N2a cells is associated with transient hyperphosphorylation of neurofilament heavy chain and ERK 1/2. Toxicol Appl Pharmacol 308:20–31
Skelding KA, Rostas JA (2020) Regulation of multifunctional calcium/calmodulin stimulated protein kinases by molecular targeting. Springer, Calcium Signaling, pp 649–679
Taylor CJ, Ireland DR, Ballagh I, Bourne K, Marechal NM, Turner PR, Bilkey DK, Tate WP, Abraham WC (2008) Endogenous secreted amyloid precursor protein-α regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory. Neurobiology of disease 31(2):250–260
Tolledo, C., M. R. Stocco, S. Miksys, F. J. Gonzalez and R. F. Tyndale (2020). "Human CYP2D6 is functional in brain in vivo: evidence from humanized CYP2D6 transgenic mice." Molecular Neurobiology: 1–12.
Trojan, J. and A. Ly (2017). Neoplastic development of CNS: 38–59.
van Spaendonck-Zwarts KY, van Hessem L, Jongbloed JD, de Walle HE, Capetanaki Y, van der Kooi AJ, van Langen IM, van den Berg MP, van Tintelen JP (2011) Desmin-related myopathy. Clin Genet 80(4):354–366
Vaquer-Alicea, J. and M. I. Diamond (2019). "Propagation of protein aggregation in neurodegenerative diseases." Annual review of biochemistry 88.
Vigouroux, C. and G. Bonne (2013). Laminopathies: one gene, two proteins, five diseases. Madame Curie Bioscience Database [Internet], Landes Bioscience.
Wang H, Pan S, Yang X, Zhu B, Wang D (2014) Oxidative phosphorylated neurofilament protein M protects spinal cord against ischemia/reperfusion injury. Neural regeneration research 9(18):1672–1677
Whitlock JR, Heynen AJ, Shuler MG, Bear MF (2006) “Learning induces long-term potentiation in the hippocampus.” Science 313(5790):1093–1097
Yuan A, Nixon RA (2016) Specialized roles of neurofilament proteins in synapses: relevance to neuropsychiatric disorders. Brain Res Bull 126(Pt 3):334–346
Yuan A, Sershen H, Basavarajappa B, Kumar A, Hashim A, Berg M, Lee J-H, Sato Y, Rao MV, Mohan PS (2015) Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in vivo. Molecular psychiatry 20(8):986–994
Yuan A, Sershen H, Veeranna BS, Basavarajappa A, Kumar A, Hashim M, Berg JH, Lee Y, Sato MV, Rao PS, Mohan V, Dyakin JP, Julien VMY, Lee and R. A. Nixon, (2015) Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in vivo. Molecular psychiatry 20(8):986–994
Zahra W, Rai SN, Birla H, Singh SS, Dilnashin H, Rathore AS, Singh SP (2020) The global economic impact of neurodegenerative diseases: opportunities and challenges. Springer, Bioeconomy for Sustainable Development, pp 333–345
Zieman A, Coulombe P (2020) Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment. Br J Dermatol 182(3):564–573
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Osemwegie, O., Ramkumar, S. & Smith, E.E. Neurodegenerative Implications of Neuronal Cytoplasmic Protein Dysfunction in Response to Environmental Contaminants. Neurotox Res 39, 533–541 (2021). https://doi.org/10.1007/s12640-020-00308-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-020-00308-8